49 articles, transcripts, and reports
Johnson & Johnson (NYSE: JNJ) saw revenue and earnings decline for the second quarter of 2020 but both the top and bottom line numbers came…
Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today. Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell 35% to $3.6…
Johnson & Johnson (JNJ) Q1 2020 earnings call dated Apr. 14, 2020. Corporate Participants: Chris DelOrefice — Vice President, Investor Relations Alex Gorsky — Chairman, Board of Directors and…
Johnson & Johnson (NYSE: JNJ) reported that its first-quarter 2020 earnings and revenue came in above the analysts’ expectations citing product sales as well as…
Johnson & Johnson (NYSE: JNJ) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Alex Gorsky — Chairman, Board of Directors…
Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations. The shares were down 1.5%…
Earnings of healthcare conglomerate Johnson & Johnson (NYSE: JNJ) increased and topped the Street view in the third quarter helped by a 2% growth in…
Johnson & Johnson (NYSE: JNJ) is slated to release its third-quarter earnings results on Tuesday, October 15, before the market opens. The results will be…
Johnson & Johnson (NYSE: JNJ), one of the first healthcare companies to publish quarterly results this season, will be reporting March-quarter results Tuesday before the…
